Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Katrina L Ellis1, Leopoldo Pérez de Isla2, Rodrigo Alonso3

  • 1School of Medicine, Faculty of Medicine and Health Sciences, University of Western Australia, Perth, Australia; School of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Western Australia, Perth, Australia.

Insights

Cascade screening for familial hypercholesterolemia (FH) effectively identifies individuals with elevated lipoprotein(a) [Lp(a)], a risk factor for atherosclerotic cardiovascular disease (ASCVD). Combining FH and Lp(a) testing enhances ASCVD risk detection in relatives.

Area of Science:

  • Cardiovascular Genetics
  • Lipid Metabolism
  • Public Health Screening

Background:

  • Familial hypercholesterolemia (FH) and elevated lipoprotein(a) [Lp(a)] are inherited conditions linked to premature atherosclerotic cardiovascular disease (ASCVD).
  • While FH cascade testing is recommended, similar guidelines for elevated Lp(a) are lacking.
  • This highlights a gap in screening strategies for these related genetic cardiovascular risk factors.

Purpose of the Study:

  • To evaluate the effectiveness of Lp(a) testing within an existing FH cascade screening program.
  • To determine if Lp(a) testing can identify individuals at higher ASCVD risk among FH relatives.
  • To assess the yield of detecting elevated Lp(a) in different FH proband subgroups.

Main Methods:

  • A cohort of 2,927 family members from 755 FH index cases (SAFEHEART study) underwent genetic FH and Lp(a) testing (≥50 mg/dl).
  • Prevalence and detection rates of elevated Lp(a) were compared between FH relatives of probands with and without high Lp(a).
  • A prospective analysis examined the association between elevated Lp(a) and ASCVD events over 5 years.

Main Results:

  • Systematic screening of FH probands with elevated Lp(a) yielded 1 new case of high Lp(a) per 2.4 individuals screened.
  • Opportunistic screening of FH probands without elevated Lp(a) identified 1 case per 5.8 individuals.
  • Both FH and elevated Lp(a) independently increased ASCVD event risk (HRs 2.47 and 3.17, respectively).
  • Individuals with both FH and elevated Lp(a) faced the highest risk (HR 4.40), independent of traditional risk factors.

Conclusions:

  • Integrating Lp(a) testing into FH cascade screening is effective for identifying at-risk relatives.
  • This combined approach enhances the detection of elevated Lp(a) and associated heightened ASCVD risk.
  • The strategy is particularly valuable when the FH proband also has elevated Lp(a).
Abstract

Related Concept Videos

Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.8K
Protein Families02:47

Protein Families

4.4K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.9K
Gene Families01:57

Gene Families

3.7K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.4K